Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Suma Krishnan Insider Profile
4 Followers
Suma Krishnan, SVP--Product Development at Precigen, holds 3.25M shares in Krystal Biotech (Ticker: KRYS), holds 113.31K shares in Precigen (Ticker: PGEN).
Profitable Transactions
4 out of 7 Profitable Transactions
Average Return
+50.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Suma Krishnan holds in companies
Most Profitable Insider Trade
The most profitable trade made by Suma Krishnan
Suma Krishnan's Trading History
Precigen
Feb 01, 2016
SVP--Product Development
Uninformative Buy
201.68K
$185.27K
Krystal Biotech
Jun 11, 2024
President, R&D, Director, Ten Percent Owner
Uninformative Sell
8.79M
$672.23M
List of latest transactions for each holding click on a transaction to see Suma Krishnan's performance on stock
You May Also Like
Suma Krishnan insider profile FAQ
What is the percentage of profitable transactions made by Suma Krishnan?
The percentage of profitable transactions made by Suma Krishnan is 57%.
What is the average return per transaction made by Suma Krishnan?
The average return per transaction made by Suma Krishnan is 50.10%.
What stocks does Suma Krishnan hold?
Suma Krishnan holds: PGEN, KRYS stocks.
What was Suma Krishnan’s latest transaction?
Suma Krishnan latest transaction was an Uninformative Sell of $8.79M.
What was Suma Krishnan's most profitable transaction?
Suma Krishnan’s most profitable transaction was an Informative Buy of PGEN stock on May 13, 2014. The return on the trade was 170.70%.
What is Suma Krishnan's role in Precigen?
Suma Krishnan's role in Precigen is SVP--Product Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.